Literature DB >> 2415878

Inhibition of inositol phospholipid breakdown by D2 dopamine receptors in dissociated bovine anterior pituitary cells.

S H Simmonds, P G Strange.   

Abstract

Inositol phospholipids have been labelled with [3H]inositol in a lactotroph-enriched preparation of dissociated bovine anterior pituitary cells. Stimulation of cells with thyrotropin-releasing hormone receptor agonists leads to accumulation of [3H]inositol phosphates, and this effect may be inhibited by dopamine (DA) agonists. The DA agonist effect may be prevented by D2 DA receptor selective antagonists. Thus the D2 receptors on these cells are linked to inhibition of inositol phospholipid metabolism, and this provides a functional assay for the receptor.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2415878     DOI: 10.1016/0304-3940(85)90588-9

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  12 in total

1.  B-HT 920 activates dopamine D2 receptors coupled to inhibition of adenylate cyclase activity.

Authors:  P Onali; M C Olianas
Journal:  J Neural Transm Gen Sect       Date:  1992

Review 2.  Pharmacological and molecular basis for dopamine D-2 receptor diversity.

Authors:  M Memo
Journal:  Mol Neurobiol       Date:  1990 Fall-Winter       Impact factor: 5.590

3.  Guanine nucleotides mediate stimulatory and inhibitory effects on cerebral-cortical membrane phospholipase C activity.

Authors:  I Litosch
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

Review 4.  The structure and mechanism of neurotransmitter receptors. Implications for the structure and function of the central nervous system.

Authors:  P G Strange
Journal:  Biochem J       Date:  1988-01-15       Impact factor: 3.857

5.  Suppression of Gi alpha 2 enhances phospholipase C signalling.

Authors:  D C Watkins; C M Moxham; A J Morris; C C Malbon
Journal:  Biochem J       Date:  1994-05-01       Impact factor: 3.857

6.  Mono- and divalent cations modulate the affinities of brain D1 and D2 receptors for dopamine by a mechanism independent of receptor coupling to guanyl nucleotide binding proteins.

Authors:  S Urwyler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-04       Impact factor: 3.000

7.  Regulation of human D(1), d(2(long)), d(2(short)), D(3) and D(4) dopamine receptors by amiloride and amiloride analogues.

Authors:  S R Hoare; M C Coldwell; D Armstrong; P G Strange
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

8.  Mechanism of dopamine mediated inhibition of neuropeptide Y release from pheochromocytoma cells (PC12 cells).

Authors:  Guihua Cao; Alice Gardner; Thomas C Westfall
Journal:  Biochem Pharmacol       Date:  2007-01-07       Impact factor: 5.858

9.  Neonatal dopamine lesion in the rat results in enhanced adenylate cyclase activity without altering dopamine receptor binding or dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein (DARPP-32) immunoreactivity.

Authors:  J Luthman; E Lindqvist; D Young; R Cowburn
Journal:  Exp Brain Res       Date:  1990       Impact factor: 1.972

10.  Effect of chronic haloperidol treatment on dopamine-induced inositol phosphate formation in rat brain slices.

Authors:  R Li; D M Chuang; R J Wyatt; D G Kirch
Journal:  Neurochem Res       Date:  1994-06       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.